Results 71 to 80 of about 24,464,352 (186)
Infection and Drug Resistance, 2020 Ziyan Kong,1,2,* Xuemei Liu,3,* Chenxi Li,1,* Siyun Cheng,1 Fei Xu,3 Bing Gu1,4 1Medical Technology School, Xuzhou Medical University, Xuzhou, Jiangsu Province, People’s Republic of China; 2Department of Laboratory Medicine, The First People&rsquo ...
Kong Z, Liu X, Li C, Cheng S, Xu F, Gu B
doaj
Melting temperatures of KPC-2 and variants.
, 2015 Melting temperatures of KPC-2 and variants.
Timothy Palzkill (47788) +2 more
core +1 more source
Plasmid-Mediated Transmission of KPC-2 Carbapenemase in Enterobacteriaceae in Critically Ill Patients [PDF]
Frontiers in Microbiology, 2019 Carbapenem-resistant Enterobacteriaceae (CRE) cause health care-associated infections worldwide, and they are of severe concern due to limited treatment options. We report an outbreak of KPC-2-producing CRE that was caused by horizontal transmission of a promiscuous plasmid across different genera of bacteria and hospitals in Germany.
Christian Schweizer +11 more
openaire +5 more sources
, 2018 The imipenem-relebactam combination is in development as a potential treatment regimen for infections caused by Enterobacteriaceae possessing complex β-lactamase backgrounds.
Krisztina M. Papp-Wallace +9 more
core +1 more source
Emerging Klebsiella pneumoniae Isolates Coproducing KPC-2 and VIM-1 Carbapenemases [PDF]
Antimicrobial Agents and Chemotherapy, 2009 VIM-1-producing Klebsiella pneumoniae strains, increasingly isolated in Greece since 2002, constitute the majority of multiresistant clinical isolates of this species found in most Greek hospitals ([9][1]).
Giakkoupi, P. +7 more
openaire +3 more sources
Resistance profiles of KPC-2-producing bacteria isolated from the WWTP for key antibiotics.
, 2016 Resistance profiles of KPC-2-producing bacteria isolated from the WWTP for key antibiotics.
Hao Zhou (136535) +3 more
core +1 more source
Early Dissemination of KPC-2-Producing Klebsiella pneumoniae Strains in Brazil [PDF]
Antimicrobial Agents and Chemotherapy, 2009 A recent publication by Monteiro et al. reported the first detection of KPC-2 β-lactamase in carbapenem-resistant Klebsiella pneumoniae strains in Brazil, which occurred in 2006 ([5][1]).
Mónica, Pavez +2 more
openaire +3 more sources
Isolation of a Klebsiella pneumoniae isolate of sequence type 258 producing KPC-2 carbapenemase in Korea [PDF]
, 2011 Carbapenem-resistant Klebsiella pneumoniae isolates producing K. pneumoniae carbapenemases (KPC) were first reported in the USA in 2001, and since then, this infection has been reported in Europe, Israel, South America, and China. In Korea, the first KPC-
용동은 +7 more
core +1 more source
Emergence of Raoultella ornithinolytica Coproducing IMP-4 and KPC-2 Carbapenemases in China [PDF]
Antimicrobial Agents and Chemotherapy, 2015 ABSTRACT We report here the emergence of seven IMP-4-producing Raoultella ornithinolytica isolates obtained from one patient. All isolates carried the bla IMP-4 carbapenemase gene, five isolates also carried bla SHV-12 , four contained
Beiwen, Zheng +8 more
openaire +2 more sources
npj Antimicrobials and ResistanceCeftazidime-avibactam (CZA) is currently one of the last resorts used to treat infections caused by carbapenem-resistant Enterobacteriaceae and Pseudomonas aeruginosa.
Longjie Zhou +10 more
doaj +1 more source